Display Settings:

Format

Send to:

Choose Destination

    J Chromatogr A. 2001 Apr 13;913(1-2):447-53.

    Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography.

    Simon VA, Thiam MD, Lipford LC.

    Department of Health, State of Florida, Jacksonville 32202, USA.

    Two high-performance liquid chromatographic methods using UV detection are presented for the determination of two different groups (A and B) of drugs used in the suppression of human immunodeficiency virus (HIV). Group A is comprised of six nucleosidic reverse transcriptase inhibitors, viz. zalcitabine, lamivudine, stavudine, didanosine, zidovudine and ziagen. Group B consists of seven drugs four of which are protease inhibitors (PIs) and three of which are non-nucleosidic reverse transcriptase inhibitors (NNRTIs). The PIs are: indinavir, nelfinavir, saquinavir and ritonavir. The NNRTIs are: nevirapine, delavirdine and efavirenz. Groups A and B require separate aliquots of serum for extraction and must be chromatographed separately.

    PMID: 11355843 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information